Financial statements Therapeutica
Balance sheet data of THERAPEUTICA
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 10 774 524,96 | 11 405 506,03 | 11 224 624,06 | 11 631 689,32 |
| A. Fixed assets | 4 858 207,10 | 4 450 992,35 | 4 034 145,55 | 3 558 496,45 |
| B. Current assets | 5 916 317,86 | 6 954 513,68 | 7 190 478,51 | 8 073 192,87 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 10 774 524,96 | 11 405 506,03 | 11 224 624,06 | 11 631 689,32 |
| A. Equity | 7 231 738,90 | 7 305 527,53 | 7 201 418,73 | 6 844 063,66 |
| B. Liabilities and provisions for liabilities | 3 542 786,06 | 4 099 978,50 | 4 023 205,33 | 4 787 625,66 |
| I. Long-term liabilities | 1 378 192,61 | 1 633 871,00 | 1 607 584,79 | 1 222 746,50 |
| II. Short-term liabilities | 2 137 193,83 | 2 457 771,00 | 2 391 343,98 | 3 546 887,27 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.